Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - TOTAL LIABILITIES
Total Liabilities URGN - UroGen Pharma Ltd.
244 M
LAST VALUE
47.90%
2 YEAR CAGR
78.43%
5 YEAR CAGR
86.28%
10 YEAR CAGR